World Congress on Gastrointestinal Cancer:
Asian Perspectives
27-28 August 2010
Hong Kong SAR, People's Republic of China
Kowloon Shangri-La Hotel
Friday, 27 August 2010
8:00
Welcome and introduction
Eric Van Cutsem, MD, PhD and
Yoon-Koo Kang, MD, PhD
Session I: Epidemiology
8:05
Epidemiology and causes of GI cancer
Wai-Keung Leung, MD
Session II: Esophageal cancer
Moderator: Virote Sriuranpong, MD, PhD
8:25
Surgery for esophageal cancer
Ke-Neng Chen, MD, PhD
8:45
Multimodality treatment of esophageal cancer
Jong Hoon Kim, MD, PhD
9:05
The role of retrievable stents in malignant esophageal strictures
Ho-Young Song, MD, PhD
9:25
Case discussion on the management of esophageal cancer
Moderator: Virote Sriuranpong, MD, PhD
Panel: Jong Hoon Kim, MD, PhD, Ho-Young Song, MD, PhD, and Ke-Neng Chen, MD, PhD
9:50
Break and poster viewing
Session III: Gastric cancer
Moderator: Yoon-Koo Kang, MD, PhD
10:15
Diagnosis and endoscopic management of early gastric cancer
Hwoon-Yong Jung, MD, PhD, AGAF
10:40 Surgical management of gastric cancer
Han-Kwang Yang, MD, PhD
11:00
Chemotherapy of advanced gastric cancer
Winnie Yeo, MD, FRCP, FHKAM
11:20 Selected abstract presentation on gastric cancer (II): QOL analysis of ToGA study
Taroh Satoh, MD
11:35
Selected abstract presentation on gastric cancer (III): AVAGAST trial
Atsushi Ohtsu, MD, PhD
11:50
Case discussion: Early disease case - endoscopic resection vs laparoscopic resection vs open surgery, advanced disease case - neoadjuvant chemo vs adjuvant chemo
Moderator: Yoon-Koo Kang, MD, PhD
Panel: Eric Van Cutsem, MD, PhD, Hwoon-Yong Jung, MD, PhD, AGAF, Han-Kwang Yang, MD, PhD, Winnie Yeo, MD, FRCP, FHKAM, and Atsushi Ohtsu, MD, PhD
12:15
General session adjourns
12:40
Lunch Symposium
Targeting to improve outcomes in advanced neuroendocrine tumors, gastric cancer and hepatocellular carcinoma: Clinical impact of mTOR therapy
Supported by Novartis Oncology
14:10
Symposium adjourns
Session IV: Hepatobiliary tumors
Supported by sanofi-aventis
Moderator: Anthony TC Chan, MD, FRCP
14:30
Introduction
Sumitra Thongprasert, MD
14:40
Surgical & non-surgical management of HCC
Ronnie Poon, MD
15:00
Radiation therapy for HCC
Jinsil Seong, MD, PhD
15:20
Chemotherapy as a foundation in the treatment of HCC
Xiao-Yu Yin, MD, PhD
15:40
Targeted therapy: Future development in HCC
Ann-Lii Cheng, MD, PhD
16:00
Case discussion
Moderator: Ann-Lii Cheng, MD, PhD
Panel: Verote Sriuranpong, MD, PhD and Xiao-Yu Yin, MD, PhD
Case 1: Chiun Hsu, MD, PhD
Case 2: Jae-Yong Cho, MD, PhD
16:25
Discussion
16:30 Break
Session V: Pancreatic cancer
Moderator: Alex Y. Chang, MD
16:50
Surgical management of pancreatic cancer
Wai Key Yuen, MBBS, FRCS, FRACS, FACS, FHKAM
17:10
Multimodality treatment
Jin Li, PhD
17:30
Case discussion on the management of pancreatic cancer
Moderator: Jin Li, PhD
Panel: Alex Y. Chang, MD and Wai Key Yuen, MBBS, FRCS, FRACS, FACS, FHKAM
17:55
Closing remarks
18:00
Adjourn
Saturday, 28 August 2010
8:30
Welcome and introduction
Eric Van Cutsem, MD, PhD and Yoon-Koo Kang, MD, PhD
Session VI: Localized colorectal cancer
Moderator: John R. Zalcberg, MD, PhD
8:35
Surgical management of rectal cancer
Michael Choti, MD, MBA
8:55
Adjuvant therapy for colorectal cancer
Tae-Won Kim, MD, PhD
Session VII:
Advanced colorectal cancer
Moderator: Anthony TC Chan, MD, FRCP
9:15
What is the optimal cytotoxic regimen in advanced colorectal cancer?
Jin Li, PhD
9:35
Predictive molecular markers in colorectal cancer
Jee Hyun Kim, MD, PhD
9:55
EGFR inhibitors in metastatic colorectal cancer
Peter Man-Lung Teo, MD
10:15
Angiogenesis inhibitors in metastatic colorectal cancer
Brigette Ma, MBBS, FRACP
10:35
Optimal neo-adjuvant chemotherapy for the management of liver metastases
Jaw-Yuan Wang, MD, PhD
10:55
Break
Session VIII: Management of mCRC patients in clinical practice: Case discussion
Supported by Merck Serono
11:10
Personalizing treatment: A new standard for prolonging overall survival in mCRC
Eric Van Cutsem, MD, PhD
11:25
Case 1: Cetuximab brings curative treatment possible
Kefeng Ding, MD
Case 2: A case of large bilateral synchronous colorectal liver metastases
B. K. Smruti, MD
Case 3: A young man with aggressive advanced colorectal cancer
Thomas Yau, MD
11:55
Discussion
Moderator: Siu Pin Choo, MD
Panel: Eric Van Cutsem, MD, PhD
Session IX: Highlights from 2010 in GI cancer management
Moderator: Eric Van Cutsem, MD, PhD
12:15
Biological markers in GI cancer
Mario Dicato, MD
12:35
Emerging targets in gastric cancer
John R. Zalcberg, MD, PhD
12:55
Highlights from ASCO and World Congress on upper gastrointestinal cancer
Eric Van Cutsem, MD, PhD
13:15
Closing remarks
13:20
Adjourn



